Jentadueto xr cost?

Jentadueto XR Cost and Availability

Jentadueto XR, a fixed-dose combination of empagliflozin (Jardiance) and linagliptin (Tradjenta), is an oral anti-diabetic medication approved for the treatment of type 2 diabetes [1]. The cost of Jentadueto XR can vary depending on several factors, including location, insurance coverage, and pharmacy.

Manufacturer and Patent Information

Boehringer Ingelheim, the manufacturer of Jentadueto XR, holds a patent for the medication that was set to expire in 2024. However, a 2020 patent litigation between Boehringer Ingelheim and Sun Pharma resulted in a settlement that allowed Sun Pharma to launch its own version of Jentadueto XR in 2024 [2]. This could potentially lead to increased competition and lower prices for the medication.

Current Cost and Insurance Coverage

As of 2023, the average cost of Jentadueto XR in the United States is around $800 for a 30-day supply [3]. However, the actual cost may be higher or lower depending on insurance coverage and patient assistance programs available. It is essential to consult with a healthcare provider or pharmacist to determine the specific cost and available options for Jentadueto XR.

Patient Assistance Programs and Coupons

Patients may be eligible for patient assistance programs or coupons to help reduce the cost of Jentadueto XR. These programs are often provided by the manufacturer, pharmaceutical companies, or advocacy groups. It is recommended to contact Boehringer Ingelheim or a patient advocacy group to explore available options.

Generic and Biosimilar Availability

While a generic version of Jentadueto XR is not yet available on the market, Sun Pharma's version as part of the patent settlement may offer lower-cost options for patients. Biosimilar versions of the medication may also become available in the future, which could further increase competition and drive down prices.

Conclusion

The cost of Jentadueto XR can vary depending on several factors, including location, insurance coverage, and pharmacy. As the patent for the medication is set to expire in 2024, increased competition and lower prices may become available.

References

[1] Jentadueto XR FDA Label

[2] Boehringer Ingelheim and Sun Pharma settle patent dispute

[3] GoodRx Price List (Jentadueto XR)

Sources:

- [1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202254s000lbl.pdf
- [2] https://www.reuters.com/article/us-boehringer-sun-pharma-idUSKBN1YM1F7
- [3] https://www.goodrx.com/price/jentadueto-xr